Monomethyl Fumarate
Adult Nasal Type Extranodal NK/T-cell Lymphoma
University of Medicine and Dentistry of New JerseySmall moleculePhase 2Dormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 81/ 100
Competitive context
20 Active assets in the Adult Nasal Type Extranodal NK/T-cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Tarapeutics Science Inc. | Phase 4 | BB |
DEXAMETHASONE Rong Tao | Phase 4 | BB |
cc-5013 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Phase 4 | BB |
Cediranib Morphotek | Phase 2 | BB |
CYCLOSPORIN A Fred Hutchinson Cancer Center | Phase 2 | BB |
View all 50 →
Same molecule, other indications
Monomethyl Fumarate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →